Next Article in Journal
Moderating Role of Health Literacy on the Association between Alexithymia and Depressive Symptoms in Middle School Students
Previous Article in Journal
Influence of Environmental Tobacco Smoke and Air Pollution on Fetal Growth: A Prospective Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJERPH
Volume 17
Issue 15
10.3390/ijerph17155320
ijerph-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Hyponatremia in Infectious Diseases—A Literature Review

by
Anna L. Królicka
1,
Adrianna Kruczkowska
1,*,
Magdalena Krajewska
2 and
Mariusz A. Kusztal
2
1
Faculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland
2
Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2020, 17(15), 5320; https://doi.org/10.3390/ijerph17155320
Submission received: 15 June 2020 / Revised: 15 July 2020 / Accepted: 21 July 2020 / Published: 23 July 2020
(This article belongs to the Section Infectious Disease Epidemiology)
Browse Figures
Review Reports Versions Notes

Abstract

:
Hyponatremia is one of the most common water–electrolyte imbalances in the human organism. A serum sodium concentration threshold of less than 135 mmol/L is diagnostic for hyponatremia. The disorder is usually secondary to various diseases, including infections. Our review aims to summarize the diagnostic value and impact of hyponatremia on the prognosis, length of the hospitalization, and mortality among patients with active infection. The scientific literature regarding hyponatremia was reviewed using PubMed, ClinicalKey, and Web of Science databases. Studies published between 2011 and 2020 were screened and eligible studies were selected according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement and specific inclusion criteria. The most common infections that were associated with hyponatremia were viral and bacterial infections, including COVID-19 (coronavirus disease 2019). The etiology varied according to the infection site, setting and patient cohort it concerned. In several studies, hyponatremia was associated with prolonged hospitalization, worse outcomes, and higher mortality rates. Hyponatremia can also play a diagnostic role in differentiating pathogens that cause a certain infection type, as it was observed in community-acquired pneumonia. Although many mechanisms leading to hyponatremia have already been described, it is impossible with any certainty to ascribe the etiology of hyponatremia to any of them.

1. Introduction

Hyponatremia is defined as a low sodium concentration in blood serum. The sodium concentration below the lower reference limit of 135 mmol/L is diagnostic for this disorder. Hyponatremia is one of the most commonly known water–electrolyte imbalances in the human organism. Its prevalence reaches 15–30% among hospitalized patients, which is even higher in the intensive care units (ICU), where it reaches up to 40% [1,2]. The incidence of hyponatremia in the general population is estimated at about 1.74%, according to National Health and Nutrition Examination Survey [3]. It is worth mentioning that in both in-patient and out-patient settings, hyponatremia is an acknowledged mortality predictor, although its causes are different in these populations [4]. Furthermore, hyponatremia prevalence was shown to be positively associated with comorbidity, expressed as Charlston Comorbidity Index, and was more profound among the most moribund patients [5]. Winzler et al. also emphasize that 1-year mortality among patients admitted to hospital due to severe hyponatremia (<125 mmol/L) reached 20% in their study, which underlines the gravity of this pathology and the need for adequate causal treatment. A recently performed meta-analysis has confirmed that the improvement of hyponatremia is independently associated with the reduction of all-cause-mortality risk [4].
Hyponatremia may occur as a result of numerous disorders [6]. These include common infectious diseases as well as endocrine, nutritional, metabolic, cardiovascular, renal or hepatic pathologies. It is worth mentioning that hospital-associated hyponatremia includes admission hyponatremia and hospital-acquired hyponatremia, which may be associated with different outcomes [7].
Patients presenting with hyponatremia may often be asymptomatic, which applies especially to elderly patients or patients with mild hyponatremia. On the contrary, most moderate to severe, as well as acute cases of hyponatremia present a broad spectrum of symptoms as nausea, confusion, headache, vomiting, which in severe cases may progress to delirium, impaired consciousness, and seizures [8]. Due to its non-specific presentation, many healthcare professionals are not aware of the association of hyponatremia and ongoing inflammation [9].
The primary purpose of this review was to perform a meta-analysis, which would elucidate the impact of hyponatremia on the prognosis, mortality, and outcomes among in-patients with an acute infective process. However, after selecting eligible papers and analyzing the available data, these were deemed insufficient for a meta-analysis by a certified statistician and instead a review has been written instead. Although the paper does not strictly meet the definition of a systemic review, we have decided to still adhere to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) model as to ensure the highest quality of the selected material and scientific content.

1.1. Pathogenesis of Hyponatremia

Sodium and potassium are the main osmotically active inorganic substances and their plasma concentrations are maintained within a narrow range [6,10]. The water transfers between intra and extracellular compartments are driven by an osmotic pressure gradient exerted by osmotically active solutes, including sodium. The amount of active osmolytes in serum is expressed by tonicity, which is a substantial parameter utilized for distinguishing between hyponatremia causes. Thus, for diagnostic purposes hyponatremia can be divided into hypotonic and non-hypotonic hyponatremia, as presented on Figure 1 [1,6].

1.2. Hypotonic Hyponatremia

Hypotonic hyponatremia is associated with serum osmolality values of less than 275 mOsm/kg [1]. It can be classified into the following three groups: hypovolemic, euvolemic, or hypervolemic hypotonic hyponatremia. The diagnosis is made depending on extracellular volume status. The most commonly utilized tools for volemic estimation are clinical assessment, inferior vena cava or central venous pressure measurement, as well as a lung ultrasound [11]. Each of these methods has certain limitations and should be used supplementary to each other to ensure proper volemia assessment [6].

1.2.1. Hypotonic Hypovolemic Hyponatremia

This type of hyponatremia is characterized by extracellular fluid volume depletion secondary to a deficit of both total body sodium and water. Baroregulated secretion of vasopressin in response to hypovolemia and inappropriate oral or parenteral hypotonic fluid intake leads to water retention, causing hyponatremia [12]. Solute loss can be classified as renal, due to salt-wasting nephropathy or mineralocorticoid deficiency, and non-renal causes. Exemplary causes of non-renal hypovolemic hyponatremia include skin losses as a consequence of burns or perspiration and gastrointestinal losses such as diarrhea or vomiting, which are often associated with infections [1,6]. Cerebral salt wasting syndrome (CSWS) is also a cause of hypovolemic hyponatremia. CSWS is sporadically observed in patients with intracranial pathologies. A variety of infections of the central nervous system (CNS) such as tuberculous meningitis, poliomyelitis, and toxoplasmosis have also been linked to CSWS [13]. The clinical signs of this type of hyponatremia include dry mucous membranes, decreased skin turgor, tachycardia, hypotension, raised urea, and creatinine levels in serum [12].

1.2.2. Hypotonic Euvolemic Hyponatremia

Euvolemic hyponatremia is the most common cause of hyponatremia among hospitalized patients [12]. The most frequent underlying disorder is Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH). SIADH is defined as the presence of hypoosmolality when urine osmolality is inappropriately high and there is no evidence of renal salt wasting or hypovolemia in an individual with normal organ functions. In SIADH, high antidiuretic hormone (ADH) activity is considered to be inappropriate, since there is no identifiable osmotic or hemodynamic stimulus for its secretion [6]. The most common causes of SIADH are malignancies, pulmonary disorders such as community-acquired pneumonia, central nervous system disorders, and drugs [6,13,14]. In HIV/AIDS patients, opportunistic infections of the pulmonary tract or CNS can also induce the release of excessive ADH [15].
In rare cases, patients may develop hyponatremia due to true volume depletion, glucocorticoid deficiency, polydipsia, malnutrition, or severe hypothyroidism [6,16,17]. Sometimes, long-lasting physical activity and diet poor in sodium may also be a reason of hypovolemic or euvolemic hyponatremia.

1.2.3. Hypotonic Hypervolemic Hyponatremia

Hypervolemic hyponatremia occurs in states such as decompensated heart failure, advanced liver disease or renal disease, where excessive water causes plasma dilution [8]. In liver diseases with cirrhosis at their end-stage, lacking mineralocorticoid elimination leads to excessive water and salt retention, while low blood albumin levels induce a water shift from vessel lumen into the tissue compartment [18]. Such a constellation leads to hypervolemia, edemas, and finally hypervolemic hyponatremia. On the contrary, in heart failure, decreased cardiac output and venous congestion are the primary underlying pathologies, leading to impaired water elimination in the kidneys, volume overload, and secondary sodium dilution [19]. Thus, the treatment of this hyponatremia type relies mainly on diuretics use and proper management of the underlying disorder.

1.3. Non-Hypotonic Hyponatremia

There are two types of nonhypotonic hyponatremia: pseudohyponatremia and hypertonic hyponatremia. Hypertonic hyponatremia occurs due to an increased concentration of osmotic active agents as mannitol or excess glucose. The mentioned sugars earlier are osmotically active substances and they do not cross freely into the cell, causing water movement [20]. As a consequence, water transfers from the intracellular compartment to the extracellular compartment.
Pseudohyponatremia is hyponatremia occurring along with isotonic osmolality. It is mainly caused by the displacement of serum water because of elevated concentrations of serum lipids or proteins. Expansion of the lipid or protein portion decreases the water portion resulting in artificially lowered serum sodium compared with serum measured directly in the water portion of plasma volume [6,20].

2. Materials and Methods

We performed a systematic search of the literature in June 2020. Research terms comprised a combination of words: “hyponatremia”, “adults”, “infection”, and “SIADH”. We analyzed the articles, which were published between 2011 and 2020, as a similar meta-analysis was carried out and released in 2011 [9]. Only English papers were reviewed. The articles were evaluated according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocol (Figure 2) and were included after fulfilling following inclusion criteria.
Inclusion criteria:
  • Age >18 years old,
  • Infection and concomitant hyponatremia in the study group,
  • Original articles.
Exclusion criteria:
  • Case reports,
  • Cases series.
Finally, 62 articles were found eligible as presented on the flowchart below and representative information was investigated.

3. Hyponatremia Due to Infections

During the literature search, we identified the following infection-related causes of hyponatremia: viral infections, bacterial infections, fungal infections, and protozoal infections. The most prevalent microorganisms within each group are presented in Table 1. In several papers, hyponatremia has been reported as a concomitant finding in patients with mixed infections.

3.1. Viral Infections

3.1.1. Influenza Virus and other Respiratory Viruses

In general population community-acquired pneumonia (CAP) is one of the most common viral infections associated with hyponatremia. Although CAP is mainly caused by bacteria such as Streptococcus pneumoniae or Legionella pneumophila, viruses still remain a relevant etiologic factor for CAP and secondary bacterial pneumonias. The main viral pathogens causing CAP are rhinovirus, respiratory syncytial virus, influenza viruses, parainfluenza viruses, and adenovirus [21]. Yet, in many cases the cause of CAP remains unidentified. CAP was one of the complications of influenza A(H1N1) infection in 2009 during the pandemic and it was associated with high morbidity, mortality, and frequent admission to ICU [22]. According to data, most of the incidences of influenza cases during the post-pandemic season period occurred in the first weeks of 2011 with dominant viral CAP etiology [22]. Previous studies revealed that among patients diagnosed with CAP, an etiological diagnosis could be established only in 42.2% of them, with 21.9% of them being infected by bacteria, 16.7% by viruses, and 4.8% of patients had mixed infection (bacterial and viral). Patients that required ICU admission were mainly affected by influenza A (H1N1) virus and influenza B virus infection. What is more, the patient cohort with viral pneumonia was younger and was less moribund than the group with non-viral pneumonia. Those with viral and mixed pneumonia, not only required ICU admission more often but also had a higher in-hospital mortality. Severe disease occurred in 16.6% of patients. Hyponatremia was independently associated with disease severity and was found in 17.6% of patients with viral pneumonia, 13.8% of patients with bacterial pneumonia, 11.1% of patients with mixed pneumonia, and 5.4% of patients with pneumonia of undetermined etiology. Hyponatremia at admission was also associated with a longer hospital stay [23]. According to these findings, hyponatremia occurs most frequently when patients suffer from viral and bacterial pneumonia and is less frequent in patients with unknown etiology of CAP [22].
Low serum sodium concentrations along with other dyselectrolytemias were also identified in patients with avian-origin influenza A(H7N9). On initial presentation, hypokalemia, hyponatremia, and hypocalcemia were common. Almost half of the patients with confirmed H7N9 infection (43.6%) were hyponatremic [24].

3.1.2. HIV Infections

Hyponatremia is a very common electrolyte abnormality among patients with AIDS [15]. According to literature, hyponatremia may occur in 20–80% of hospitalized patients with HIV disease or AIDS [15]. A common comorbidity in HIV-infected patients are pulmonary or CNS infections, which may result in SIADH. It may explain why hyponatremia is inherent in this disease.
Hyponatremia also occurs as a result of adrenal insufficiency, renal disorders, and gastrointestinal sodium loss due to diarrhea and vomiting, which are observed frequently in AIDS patients [25,26,27]. According to studies, there is a positive correlation between serum sodium concentrations and the number of CD4+ cells, as hyponatremic patients presented with lower CD4+ cell count and showed a negative correlation with the WHO clinical stage [27,28]. This may suggest that serum sodium concentrations can be used as an indicator of the progression of HIV-infection or AIDS, although it is not a specific marker. What is more, a significantly higher proportion of patients with hyponatremia are hospitalized at first contact, the time between the diagnosis and their first hospitalization is shorter, and they have a higher incident hospitalization rate compared to normonatremic patients [28].
Despite numerous observations that link hyponatremia development with HIV-disease progression, it still remains a topic of controversy whether hyponatremia does directly increase the mortality among HIV infected patients. Currently, there is no strong data that would confidently support such a thesis. Braconnier et al. reported a similar amount of HIV-related deaths in hypo- and normonatremic patients at baseline [28]. In the same study it has also been reported that hyponatremic patients presented a higher all-cause mortality, which has been linked to lower CD4 count and higher prevalence of hepatitis C. On the other hand, moderate to severe hyponatremia was shown to be associated with higher long-term mortality [27]. What is more, the majority of HIV-infected deaths occurred within the first 3 months of anti-retroviral therapy initiation, and hyponatremia was independently associated with mortality. It has also been observed that serum chloride and serum sodium levels are regulated together, and hyponatremia is frequently associated with hypochloremia, which leads to higher mortality, compared to patients with only one electrolyte abnormality. Dao et al. have also suggested that subsequent mortality may also be caused by undiagnosed conditions primary to these electrolyte abnormalities and not by the electrolyte abnormality itself [29].
Despite the fact that SIADH is considered to be one of the factors leading to hyponatremia in HIV-infections or AIDS, no differences between the ADH, renin, or aldosterone levels of HIV patients and those of non-HIV-infected subjects were observed [30]. Currently, there is no strong data that would support the thesis that hyponatremia may contribute directly to increased mortality among HIV-infected patients. That is why it should only be treated as a surrogate marker of the severity of the underlying disease.

3.1.3. Coronaviruses Infections

Early reports analyzing COVID-19 (Coronavirus Disease 2019) show that hyponatremia may be a common laboratory finding among infected patients [31]. However, different reports show that hyponatremia in this patient cohort may not only be associated with COVID-related pneumonia, but may also be attributed to inadequate dietary intake by COVID-19 patients or the gastrointestinal presentation of the disease. In patients described by Yiqun Wu et al., 17.6% of the study group presented with hyponatremia. Irrespectively from the hyponatremia etiology, it appeared more frequently in patients with a hospital stay longer than 14 days. Nonetheless, in a multivariate analysis, it was not recognized as an independent risk factor associated with long-term hospitalization in patients with COVID-19. [32]. Berni et al. reported that among non-ICU, COVID-patients, hyponatremia correlated positively with oxygenation index (PaO2/FiO2 ratio) and inversely with IL-6 levels. The investigated patient cohort in this study was partially qualified for tocilizumab (anti-IL6 antibody) treatment, based on IL-6 levels. Interestingly, the initiation of such treatment was associated with significant improvement of hyponatremia at 48 h, as compared to control group [33]. The authors of this study also emphasize that hyponatremic patients have presented worse outcome (more ICU-transfers and more non-invasive ventilation initiations) than their normonatremic counterparts. No information about long-term outcomes in patients treated with tocilizumab have been presented in this study.
Therefore, further research has to be carried out to state the role of hyponatremia in this new disease and to explore its possible association with response to treatment, morbidity, time of hospitalization, and mortality.

3.1.4. Other Viral Infections

Other viral infections associated with hyponatremia include human herpesvirus-6 (HHV-6), SFTS virus (SFTSV), hantavirus, herpes simplex virus (HSV), and Ebola virus infections [34,35,36,37,38,39,40].
Severe fever with thrombocytopenia syndrome (SFTS) is an infectious disease caused by the SFTSV. Retrospectively, SFTSV infections are uncommon but are associated with high mortality, reported at the level of 33% [34]. Hyponatremia was found to be an independent risk factor of death in SFTS patients. In the non-survivor group, hyponatremia occurred in 12 cases (60%), and in the survivor group in eight cases (20%). Generally, electrolyte imbalances including hyponatremia are common in SFTS and are related to higher disease severity and worse outcome.
Many papers also discuss acute CNS infections, with the main focus on encephalitis. The most common viral pathogens responsible for CNS infections are HSV, Enterovirus, and Varicella zoster virus (VZV) [35]. Hyponatremia, both hypovolemic and euvolemic is associated with all viral CNS infections due to vomiting, SIADH, or fever. That is why CNS infections are related with high incidence of hyponatremia that reaches 30–66% [36]. In general, hyponatremia is associated with CNS infections in about 30–66% of cases [36]. It has been observed that low serum sodium levels appear more frequently in CNS HSV infections. Thus, it has been suggested that serum sodium could be used to differentiate the HSV vs. non-HSV encephalitis etiology [36,37].
The reactivation of human herpesvirus-6 latent infection has been reported after allogeneic hematopoietic stem cell transplantation, leading to CNS disorders such as myelitis and encephalitis [38]. At the onset of HHV-6 encephalitis, serum sodium level decreased in all patients with encephalitis (median of 129.1 mEq/L) and it was lower than in patients with myelitis. Some factors, for instance antineoplastic agents, glucocorticoids, calcineurin inhibitors, diuretics, and malnutrition can possibly contribute to hyponatremia. What is more, SIADH occurs in a variety of CNS disorders or infections and it may be involved in the development of hyponatremia associated with HHV-6 encephalitis [38]. Some scientists propose that hyponatremia could be a sign of HHV-6 encephalitis, but not of myelitis after allogeneic hematopoietic stem cell transplantation.
Hantavirus causes hemorrhagic fever with renal syndrome. Severe hyponatremia has been reported to be associated with this disease, predicting the development of acute kidney injury (AKI) [39].
The lowered concentration of sodium, which is a common laboratory abnormality in Ebola patients, is most probably associated with sodium and water loss due to severe vomiting and diarrhea [40]. Retrospective studies have shown that hyponatremia was present in about 44% of patients diagnosed with Ebola virus infection on admission. In the course of hospitalization its prevalence has increased up to 78% [40,41,42]. All of the patients received treatment during hospitalization.

3.2. Fungal Infections

Only one article was found, which described hyponatremia in a fungal infection—cryptococcosis. Cryptococcal infection has two most common manifestations: cryptococcal meningitis or pulmonary cryptococcosis. As a result, many mechanisms leading to hyponatremia development in this patient group must be considered. As multivariable analysis showed, hyponatremia at presentation is statistically significantly associated with cryptococcal infection [43].

3.3. Overlapping Infection

Hyponatremia has long been recognized as a complication of malaria [44]. Both malaria and HIV infections independently affect the electrolyte profiles, but not much is known how these two infections together affect the serum sodium level. According to studies, comparing four groups of patients, HIV-uninfected with uncomplicated malaria, HIV-uninfected with severe malaria, HIV-infected with uncomplicated malaria, and HIV-infected with severe malaria, there is no statistically valuable connection between HIV and malaria causing hyponatremia. Separately and together, serum sodium level is similar in these four groups [45].
Toxoplasmic encephalitis (TE) is the most frequent neurologic disorder in patients with advanced HIV infection [46]. Alterations in serum sodium regulation are a common feature in neurologic disorders like TE. Neurologic-associated hyponatremia could be secondary to SIADH. In one article, among the patients diagnosed with toxoplasmosis, hyponatremia on admission was verified in 46.7% and severe hyponatremia in 10.8% of the cases [47]. What is more, HIV-infected and TE populations are at risk of developing acute kidney injury (AKI) mainly because of the treatment for TE, where the first line medicaments are the sulfonamides. Hyponatremia was proven to be an important risk factor for developing AKI. It triggers the release of ADH, leading to increased urine concentration, which in turn predisposes to sulfadiazine crystal deposition in kidneys. In this study survivors differed from non-survivors in serum sodium levels with a significantly higher prevalence of hyponatremia (35.4% vs. 92.3%; p < 0.0001). A multivariable analysis showed that hyponatremia on admission was an independent risk factor for hospital mortality [47].
Tuberculosis is another common co-infection in HIV/AIDS patients, and it may be also associated with hyponatremia that occurred in 28.4% cases, which, together with active tuberculosis and WHO clinical stage 4 status, is thought to be an important risk factor for mortality within 6 months of admission. Additionally, it is suggested that hyponatremia was not the direct cause of death but an indicator of the critical status of the patient, as deaths still occurred even after the patient’s serum sodium levels had been corrected [48].

3.4. Bacterial Infections

The most common topic among articles concerning bacterial infections was CAP, where low serum sodium is one of the most frequent laboratory findings [49]. There are many theories about the association of hyponatremia with infections; however, the etiology remains unclear despite the many attempts to identify it. There is a study that ruled out SIADH being the cause of hyponatremia in Legionnaires’ disease by measuring and finding no connection between CT-ProVasopressin and sodium levels [50].
Some studies suggest that hyponatremia can be a useful marker in differentiating Legionella pneumophila from Streptococcus pneumoniae or other non-legionella pneumophila infections [51,52]. The utility of pneumonia pathogen identification relies on the fact that L. pneumophila, unlike other pneumonia-typical pathogens, seems to be strongly associated with severe respiratory symptoms as well as sepsis with multiorgan dysfunction [53]. First line antibiotics for pneumonia treatment, such as amoxicillin or other beta-lactams, do not possess antimicrobial activity against this pathogen. Thus, easy and commonly available tests that could predict L. pneumophila infections with good sensitivity could prove useful, as different treatment is required by this pathogen.
Patients with L. pneumophila tend to have lower serum sodium levels than patients with pneumonia caused by other pathogens [52]. It has also been shown that hyponatremia is positively associated with L. pneumophila Urinary Antigen Test positive result [54]. Still, there is no perfect scoring system that would differentiate these bacteria from others. In the six-point scoring system proposed in the cited article, the cut off value of serum sodium is 133 mmol/L, while the four-point scoring system defines it at 137 mmol/L. However, there are studies proving that the six-point scoring system is of no use and in many cases may lead to a misdiagnosis. That is why a microbiological investigation still remains the best way of confirming Legionella pneumonia infection [52,55,56].
Nonetheless, hyponatremia in CAP is associated with higher mortality and longer in-hospital stay [57]. Although in most cases hyponatremia was only mild to moderate, it still resulted in relevant clinical symptoms [49].
Other articles about hyponatremia in bacterial infections included peritonitis, tuberculosis, murine typhus, sepsis, bacterial meningitis, skin, and soft tissue infection, Guillain Barre Syndrome, Mediterranean spotted fever (MSF), and scrub typhus [58].
Low serum of sodium is also common in Spontaneous Bacterial Peritonitis (SBP). A retrospective case-control study revealed that, among cirrhotic patients, those with SBP suffered more frequently from hyponatremia than non-SBP patients [59]. Severe hyponatremia (<125 mmol/L) is also reported to be a risk factor of developing SBP, which may be related to higher volume overload with sodium dilution as well as intestine mucosa edema, allowing spontaneous bacterial migration through its wall [60]. Moreover, hyponatremia is commonly observed in 27% of patients who suffer from peritoneal-dialysis-related peritonitis (PDRP). In a retrospective analysis, serum sodium level was positively correlated with serum albumin and phosphate levels. In the hyponatremic group, the in-hospital stay was lengthened, and the mortality rate was higher [61,62]. Another retrospective study shows that baseline hyponatremia (<130 mmol/L) is independently associated with refractory peritonitis [63].
In miliary tuberculosis, hyponatremia is reported to be associated with an unfavorable clinical outcome and predicts the need for mechanical ventilation and critical care intervention [64]. While in miliary tuberculosis the reasons for hyponatremia remain unclear, there are studies which precisely define its etiology in tuberculous meningitis (TBM). About 45% of TBM patients had hyponatremia, with CWS and SIADH being its two main causes. This study states the predictors of hyponatremia in TBM, which are lower Glasgow Coma Scale, higher frequency of infarction in both anterior and posterior circulation, and higher incidence of basal exudates [65].
Another bacterial infection in which hyponatremia is observed is murine typhus. Its prevalence reaches up to 44% of patients, occurring more often in children than in adults [66,67].
Among patients suffering from Guillain–Barre Syndrome, the elderly (more than 60 years old) were characterized by a higher rate of hyponatremia compared to the younger group (18–59 years old) with a ratio of 25% vs. 10.2%, (p < 0.01) [68].
An analysis of the epidemiologic trend of adult bacterial meningitis reveals that the most common infections were monomicrobial, caused by Staphylococcal species. Hyponatremia was also a common laboratory finding in this disease [69].
It is well known that patients with liver cirrhosis have worse immunity and are prone to infections. These include skin and soft tissue infection, which appear to be associated not only with hyponatremia, but also renal failure. In most cases, the infection primary site is localized on the lower extremity. In patients with skin and soft tissue infection, hyponatremia occurs significantly more often, and sodium concentration, precisely the Model of End-Stage Liver Disease sodium, is associated with mortality among infected patients [70].
One article suggested that hyponatremia is of no prognostic value to predict the progression of sepsis to severe sepsis or septic shock [71].
Elderly patients with MSF suffered more frequently from hyponatremia than non-elderly MSF patients with a prevalence of 20.0% vs. 8.1% (p = 0.014), respectively [72].

3.5. Protozoal Infections

Malaria is a protozoal disease, in which hyponatremia is commonly observed in approximately 60% of the cases [73]. A hypothesis has been proposed that it is caused by a dysregulation of vasopressin release. It is also suggested that serum sodium of 131 mmol/L and lower characterizes severe falciparum malaria disease [74]. Yet, the WHO guidelines for diagnosing severe hyponatremia do not take into consideration sodium levels [75]. One of the studies identified hyponatremia as a mortality predictor, which predicted death at the cut off of 126 mEq/L with the specificity of 78.8% and sensitivity of 81.1% [73].
Another study identified hyponatremia in 66% of malaria contracted patients during antineoplastic therapy [76].

4. Other Potentially Infection-Related Causes of Hyponatremia

Many medical departments, as ICU or internal wards, deal with moribund patients who frequently develop both hyponatremia and infections in the course of hospitalization. Due to high prevalence of neoplasms, AKI, pulmonary pathologies, and other comorbidities, the etiology of hyponatremia often remains unclear. Thus, the knowledge about alternative hyponatremia causes and the distinction between them is crucial for proper decision making and patient management.

4.1. SIADH

One retrospective study aimed to analyze the difference between hyponatremia in SIADH and hyponatremia in AKI. 24.9% of patients with SIADH were diagnosed with an infection, either acute or chronic. In general, patients with SIADH were characterized by a higher median survival time compared to those with AKI. Among patients who died within the first year, 23.8% had an infection. Furthermore, mortality in the first 2.5 years after diagnosis was higher among AKI patients, but after 2.5 years it became similar in both groups [77].
Another study strived to investigate the etiology of SIADH. The main identified causes of this disorder were cancer (27.7%), drugs (26.5%), idiopathic (15.9%), pulmonary infections (12.3%), pain and nausea (10.4%), and CNS disorders (7.2%). All these groups were comprehensively described. As far as pulmonary infections were concerned, these patients presented the highest median of serum sodium concentration, most of them (45.5%) suffered from moderate hyponatremia, and their long-term (30 months) survival-rate was extremely low with 36.8%. According to this study, the etiology of SIADH is an important prognostic factor of survival [78].
The mentioned SIADHs etiology is of great importance since it determines the patient’s prognosis. That is why one center retrospective study, focused on stating the characteristics of patients diagnosed with idiopathic SIADH was performed, in an attempt to re-diagnose those patients. The researchers managed to establish a new diagnosis only in 11 out of 99 patients, while in 88 out of 99 the etiology remained idiopathic. In the group of re-diagnosed patients, seven had a malignancy detected, two had chronic pulmonary infections, one had benign brain space-occupying lesion, and one had Kikuchi syndrome [79].
Although SIADH is known to be associated with certain infections and presents a well-known clinical range of symptoms, its precise mechanism still remains uncertain. Studies designed to present a potential correlation between ADH-related peptides (as CT-ProVasopressin) and sodium serum levels have failed to do so. Thus, the pathophysiology of SIADH in infectious diseases is complex and extends beyond simple inadequate ADH secretion [50].

4.2. Other—Dysnatremia in Critically Ill Patients

One of the included articles analyzed dysnatremia among patients admitted to the ICU [80]. This multi-center prospective study, which enrolled almost 14,000 patients (51% presented with infection on admission) has shown that 12.9% of patients presented low serum sodium concentration at the moment of inclusion. All kinds of hyponatremia, mild, moderate, and severe, were connected with higher mortality, irrespective of the presence or lack of infection. A positive relationship has been noticed between the severity of hyponatremia and in-hospital mortality.

4.3. Drug—Induced Hyponatremia

Trimethoprim-sulfamethoxazole (TMP-SMX) is an antibiotic used mainly for the treatment of urinary tract infections and in the prevention of pneumocystis pneumonia. In a retrospective study, 72.3% of patients treated with this drug developed hyponatremia, 43.6% of which was moderate and severe [81]. After the termination of the therapy, serum sodium normalized within about 4 weeks in 50% of patients who had severe to moderate hyponatremia and in 60% of patients who had mild hyponatremia. Moreover, longer duration of therapy with TMP-SMX and its higher cumulative dose significantly lowered the serum sodium. Unfortunately, the pathomechanism of this state during TMP-SMX treatment remains unknown, though the authors suggest the main reason being renal salt wasting. An alternative mechanism has been suggested, that trimethoprim blocks sodium channels in the distal nephron, inducing excessive natriuresis [82].

5. Conclusions

There is no doubt that hyponatremia in infections is a multidisciplinary problem, as it may be associated with the infection itself, but also with a variety of factors such as renal or intracranial pathologies, drugs intake, malnutrition, or critical state. The knowledge about factors predisposing to hyponatremia remains essential for a proper diagnosis and treatment.
Many publications show that hyponatremia is associated with prolonged hospital stay and severity, as well as mortality in a number of infectious diseases. Despite many attempts to state its etiology in infective settings, few studies, just one in our review, took into consideration measuring the level of CT-ProVassopressin. This seems to be an adequate method to differentiate at least whether the low level of sodium is caused by SIADH or not. Therefore, we suggest including this test in the future studies of the pathomechanism of hyponatremia.
Several authors suggest that the correlation between hyponatremia during infection and mortality risk is causal, which might indeed be the case. However, it needs to be stressed that most of the infection-related deaths occur due to respiratory or circulatory failure, and not hyponatermia-associated neurologic damage. Thus, to prove the causal relationship between hyponatremia and mortality in infective settings, large prospective trials will need to be conducted in the future. Until then, in patients with infections hyponatremia should be interpreted as an indirect marker of disease severity, a potential direct marker of other concomitant disease, or a predictor of poor prognosis in this setting.
As mentioned in the introduction, it has been recently proven that improvement of hyponatremia reduces the risk of death among patients admitted to hospital due to this disorder. Therefore, there are no doubts that each case of hyponatremia should be treated causally in order to reinstate correct water–electrolyte balance in organism. Mild- and moderate hyponatremia in certain settings may be well tolerated and treated ambulatory. However, most of the studies indicate that patients with serum sodium threshold of <125 mmol/L (irrespective of their symptoms) should be immediately admitted to hospital and treated intensively, due to high mortality reaching up to 20% in these patients.
The role of hyponatremia in HIV-infection remains uncertain. These patients were mostly excluded from studies focusing on the impact of hyponatremia on prognosis and mortality, and so the results of these cannot be extrapolated on the population of HIV positive patients.
The novelties in our paper, comparing to the similar review released in 2011, include description of hyponatremia in Ebola-infected patients, in COVID-19 patients, and in influenza-infected patients.

Author Contributions

Conceptualization, M.A.K.; methodology, A.L.K., M.A.K. and A.K.; software, A.L.K.; validation, A.L.K., M.A.K., A.K.; formal analysis, A.L.K., M.K., A.K.; investigation, A.L.K., A.K.; resources, A.L.K., A.K.; data curation, A.L.K., A.K.; writing—original draft preparation, A.L.K.; writing—review and editing, A.K., M.K., M.A.K.; visualization, A.L.K., A.K.; supervision, M.A.K.; project administration, M.A.K.; funding acquisition, M.K. All authors have read and agreed to the published version of the manuscript.

Funding

The study is supported by the Wroclaw Medical University statutory funds (SUB.C160.19.055). It was an investigator-initiated research. The funding body had no role in the study design, data collection, analyses, and interpretation, or in writing the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

ADH—antidiuretic hormone; AIDS—acquired immune deficiency syndrome; AKI—acute kidney injury; CAP—community acquired pneumonia; CNS—central nervous system; COVID-19—coronavirus disease 2019; CSWS—cerebral salt wasting syndrome; HHV-6—human herpesvirus 6; HIV—human immunodeficiency virus; HSV—herpes simplex virus; ICU—intensive care unit; MSF—Mediterranean spotted fever; PRISMA—Preferred Reporting Items for Systematic Reviews and Meta-Analyses; SBP—spontaneous bacterial peritonitis; SFTS—severe fever with thrombocytopenia syndrome; SFTSV—severe fever with thrombocytopenia syndrome virus; SIADH—syndrome of inappropriate secretion of antidiuretic hormone; TBM—tuberculous meningitis; TE—toxoplasmic encephalitis; TMP-SMX—trimethoprim-sulfamethoxazole; WHO—world health organization

References

  1. Rondon-Berrios, H.; Agaba, E.I.; Tzamaloukas, A.H. Hyponatremia: Pathophysiology, classification, manifestations and management. Int. Urol. Nephrol. 2014, 46, 2153–2165. [Google Scholar] [CrossRef] [PubMed]
  2. Upadhyay, A.; Jaber, B.L.; Madias, N.E. Incidence and Prevalence of Hyponatremia. Am. J. Med. 2006, 119, S30–S35. [Google Scholar] [CrossRef] [PubMed]
  3. Mohan, S.; Gu, S.; Parikh, A.; Radhakrishnan, J. Prevalence of Hyponatremia and Association with Mortality: Results from NHANES. Am. J. Med. 2013, 126, 1127–1137. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Corona, G.; Giuliani, C.; Parenti, G.; Norello, D.; Verbalis, J.G.; Forti, G.; Maggi, M.; Peri, A. Moderate Hyponatremia Is Associated with Increased Risk of Mortality: Evidence from a Meta-Analysis. PLoS ONE 2013, 8, e80451. [Google Scholar] [CrossRef]
  5. Winzeler, B.; Jeanloz, N.; Nigro, N.; Suter-Widmer, I.; Schuetz, P.; Arici, B.; Bally, M.; Blum, C.; Bock, A.; Huber, A.; et al. Long-term outcome of profound hyponatremia: A prospective 12 months follow-up study. Eur. J. Endocrinol. 2016, 175, 499–507. [Google Scholar] [CrossRef] [Green Version]
  6. Dineen, R.; Thompson, C.J.; Sherlock, M. Hyponatraemia—Presentations and management. Clinical Medicine. J. R. Coll. Physicians Lond. 2017, 17, 263–269. [Google Scholar]
  7. Sigal, S.H.; Amin, A.; Chiodo, J.A., III; Sanyal, A. Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry. Can. J. Gastroenterol. Hepatol. 2018. [Google Scholar] [CrossRef] [Green Version]
  8. Sahay, M.; Sahay, R. Hyponatremia: A practical approach. Indian J. Endocrinol. Metab. 2014, 18, 760–771. [Google Scholar] [CrossRef]
  9. Liamis, G.; Milionis, H.J.; Elisaf, M. Hyponatremia in patients with infectious diseases. J. Infect. 2011, 63, 327–335. [Google Scholar] [CrossRef]
  10. Gankam Kengne, F. Physiopathology, clinical diagnosis, and treatment of hyponatremia. Acta Clin. Belg. Int. J. Clin. Lab. Med. 2016, 71, 359–372. [Google Scholar] [CrossRef]
  11. Mullens, W.; Damman, K.; Harjola, V.P.; Mebazaa, A.; Brunner-La Rocca, H.P.; Martens, P.; Testani, J.M.; Tang, W.; Orso, F.; Rossignol, P.; et al. The use of diuretics in heart failure with congestion—A position statement from the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 2019, 21, 137–155. [Google Scholar] [CrossRef] [PubMed]
  12. Smith, D.M.; Mckenna, K.; Thompson, C.J. Hyponatraemia. Clin. Endocrinol. 2000, 552, 667–678. [Google Scholar] [CrossRef] [PubMed]
  13. Hausman-Kedem, M.; Reif, S.; Danino, D.; Limor, R.; Grinspan, Z.M.; Yerushalmi-Feler, A.; Ben-Tov, A.; Birger, A. Mechanism of Hyponatremia in Community-Acquired Pneumonia: Does B-Type Natriuretic Peptide Play a Causative Role? Pediatric Emerg. Care 2018, 34, 641–646. [Google Scholar] [CrossRef] [PubMed]
  14. Peri, A.; Pirozzi, N.; Parenti, G.; Festuccia, F.; Menè, P. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J. Endocrinol. Investig. 2010, 33, 671–682. [Google Scholar] [CrossRef] [PubMed]
  15. Shu, Z.; Tian, Z.; Chen, J.; Ma, J.; Abudureyimu, A.; Qian, Q.; Zhuo, L. HIV/AIDS-related hyponatremia: An old but still serious problem. Ren. Fail. 2018, 40, 68–74. [Google Scholar] [CrossRef]
  16. Baylis, P.H. The syndrome of inappropriate antidiuretic hormone secretion. Int. J. Biochem. Cell Biol. 2003, 35, 1495–1499. [Google Scholar] [CrossRef]
  17. Warnera, M.H.; Holding, S.; Kilpatrick, E.S. The effect of newly diagnosed hypothyroidism on serum sodium concentrations: A retrospective study. Clin. Endocrinol. 2006, 64, 598–599. [Google Scholar] [CrossRef]
  18. John, S.; Thuluvath, P.J. Hyponatremia in cirrhosis: Pathophysiology and management. World J. Gastroenterol. 2015, 21, 3197–3205. [Google Scholar] [CrossRef]
  19. Ponikowski, P.; Voors, A.A.; Anker, S.D.; Bueno, H.; Cleland, J.; Coats, A.; Falk, V.; González-Juanatey, J.R.; Harjola, V.P.; Jankowska, E.A.; et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2016, 37, 2129–2200. [Google Scholar] [CrossRef]
  20. Buffington, M.A.; Abreo, K. Hyponatremia: A Review. J. Intensive Care Med. 2014, 31, 223–236. [Google Scholar] [CrossRef]
  21. Ruuskanen, O.; Lahti, E.; Jennings, L.C.; Murdoch, D.R. Viral pneumonia. Lancet 2011, 377, 1264–1275. [Google Scholar] [CrossRef]
  22. Viasus, D.; Marinescu, C.; Villoslada, A.; Cordero, E.; Gálvez-Acebal, J.; Fariñas, M.C.; Gracia-Ahufinger, I.; Fernández-Navarro, A.; Niubo, J.; Ortega, L.; et al. Community-acquired pneumonia during the first post-pandemic influenza season: A prospective, multicentre cohort study. J. Infect. 2013, 67, 185–193. [Google Scholar] [CrossRef] [PubMed]
  23. Karki, L.; Thapa, B.; Sah, M.K. Hyponatremia in Patients with Community Acquired Pneumonia. JNMA J. Nepal Med. Assoc. 2016, 54, 67–71. [Google Scholar] [CrossRef] [PubMed]
  24. Oliveira, D.B.; Durigon, E.L.; Carvalho, A.C.; Leal, A.L.; Souza, T.S.; Thomazelli, L.M.; Moraes, C.T.; Vieira, S.E.; Gilio, A.E.; Stewien, K.E. Epidemiology and Genetic Variability of Human Metapneumovirus During a 4-Year-Long Study in Southeastern Brazil. J. Med. Virol. 2009, 81, 915–921. [Google Scholar] [CrossRef]
  25. Xu, L.; Ye, H.; Huang, F.; Yang, Z.; Zhu, B.; Xu, Y.; Qiu, Y.; Li, L. Moderate/Severe Hyponatremia Increases the Risk of Death among Hospitalized Chinese Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Patients. PLoS ONE 2014, 9, e111077. [Google Scholar] [CrossRef]
  26. World Health Organization. Annex 1. WHO Clinical Staging of HIV Disease in Adults, Adolescents and Children; World Health Organization: Geneva, Switzerland, 2007; pp. 1–2. [Google Scholar]
  27. Musso, C.G. Water, electrolytes, and acid-base alterations in human immunodeficiency virus infected patients. World, J. Nephrol. 2016, 5, 33. [Google Scholar] [CrossRef]
  28. Braconnier, P.; Delforge, M.; Garjau, M.; Wissing, K.M.; De Wit, S. Hyponatremia is a marker of disease severity in HIV-infected patients: A retrospective cohort study. BMC Infect. Dis. 2017, 17, 1–10. [Google Scholar] [CrossRef] [Green Version]
  29. Dao, C.N.; Peters, P.J.; Kiarie, J.N.; Zulu, I.; Muiruri, P.; Ong’Ech, J.; Mutsotso, W.; Potter, D.; Njobvu, L.; Stringer, J.S.; et al. Hyponatremia, Hypochloremia, and Hypoalbuminemia Predict an Increased Risk of Mortality During the First Year of Antiretroviral Therapy Among HIV-Infected Zambian and Kenyan Women. Aids Res. Hum. Retrovir. 2011, 27, 1149–1155. [Google Scholar] [CrossRef]
  30. Wen, Y.; Ding, H.B.; Chen, W.; Zhou, Y.; Wang, W.; Wang, Y.; Lu, X.; Liu, J.; Kang, J.; Geng, W.; et al. Correlation of baseline hormonal disorders with immunological failure and mortality in male HIV patients during follow-up. Medicine (United States) 2016, 95. Available online: http://journals.lww.com/md-journal%5Cnhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed18b&NEWS=N&AN=614182369 (accessed on 28 January 2019). [CrossRef]
  31. Aggarwal, S.; Garcia-Telles, N.; Aggarwal, G.; Lavie, C.; Lippi, G.; Henry, B.M. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States. Diagnosis 2020, 7, 91–96. [Google Scholar] [CrossRef]
  32. Wu, Y.; Hou, B.; Liu, J.; Chen, Y.; Zhong, P. Risk Factors Associated With Long-Term Hospitalization in Patients With COVID-19: A Single-Centered, Retrospective Study. Front. Med. 2020, 7, 315. [Google Scholar] [CrossRef] [PubMed]
  33. Berni, A.; Malandrino, D.; Parenti, G.; Maggi, M.; Poggesi, L.; Peri, A. Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: May all ft together? J. Endocrinol. Investig. 2020. [Google Scholar] [CrossRef] [PubMed]
  34. Xu, X.; Sun, Z.; Liu, J.; Zhang, J.; Liu, T.; Mu, X.; Jiang, M. Analysis of clinical features and early warning indicators of death from severe fever with thrombocytopenia syndrome. Int. J. Infect. Dis. 2018, 73, 43–48. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Silva, M.T.T. Encefalites virais. Arquivos de Neuro-Psiquiatria. 2013, 71, 703–709. [Google Scholar] [CrossRef] [Green Version]
  36. Lim, A.K.H.; Paramaswaran, S.; Jellie, L.J.; Junckerstorff, R.K. A Cross-Sectional Study of Hyponatremia Associated with Acute Central Nervous System Infections. J. Clin. Med. 2019, 8, 1801. [Google Scholar] [CrossRef] [Green Version]
  37. Basaran, S.; Yavuz, S.S.; Bali, E.A.; Cagatay, A.; Oncul, O.; Ozsut, H.; Eraksoy, H. Hyponatremia is predictive of HSV-1 encephalitis among patients with viral encephalitis. Tohoku J. Exp. Med. 2018, 247, 189–195. [Google Scholar] [CrossRef]
  38. Murakami, K.; Kohashi, S.; Sakurai, M.; Kato, J.; Toyama, T.; Koda, Y.; Yamane, Y.; Hashida, R.; Abe, R.; Yamazaki, R.; et al. Hyponatremia associated with human herpesvirus-6 (HHV-6) encephalitis after allogeneic hematopoietic stem cell transplantation: A presentation different from HHV-6 myelitis. Int. J. Hematol. 2017, 106, 436–440. [Google Scholar] [CrossRef]
  39. Rista, E.; Pilaca, A.; Akshija, I.; Rama, A.; Harja, E.; Puca, E.; Bino, S.; Cadri, V.; Kota, M.; Nestor, T.; et al. Hemorrhagic fever with renal syndrome in Albania. Focus on predictors of acute kidney injury in HFRS. J. Clin. Virol. 2017, 91, 25–30. [Google Scholar] [CrossRef]
  40. West, T.E.; von Saint André-Von Arnim, A. Clinical presentation and management of severe Ebola virus disease. Ann. Am. Thorac. Soc. 2014, 11, 1341–1350. [Google Scholar] [CrossRef]
  41. Van Griensven, J.; Bah, E.I.; Haba, N.; Delamou, A.; Camara, B.S.; Olivier, K.J.-J.; De Clerck, H.; Nordenstedt, H.; Semple, M.G.; Van Herp, M.; et al. Electrolyte and Metabolic Disturbances in Ebola Patients during a Clinical Trial, Guinea. Emerg. Infect. Dis. 2015, 22, 2120. [Google Scholar]
  42. Uyeki, T.M.; Mehta, A.K.; Davey, R.T., Jr.; Liddell, A.M.; Wolf, T.; Vetter, P.; Schmiedel, S.; Grünewald, T.; Jacobs, M.; Arribas, J.R.; et al. Clinical Management of Ebola Virus Disease in the United States and Europe. N. Engl. J. Med. 2016, 374, 636–646. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Hamadani, B.H.K.; Franco-Paredes, C.; McCollister, B.; Shapiro, L.; Beckham, J.D.; Henao-Martínez, A.F.; Beckham, D. Cryptococcosis and cryptococcal meningitis —New predictors and clinical outcomes at a united states academic medical center. Mycoses 2018, 61, 314–320. [Google Scholar] [CrossRef] [PubMed]
  44. Van Wolfswinkel, M.E.; Hesselink, D.A.; Zietse, R.; Hoorn, E.J.; Van Genderen, P.J.J. Hyponatraemia in imported malaria is common and associated with disease severity. Malar. J. 2010, 9, 1–8. [Google Scholar] [CrossRef] [Green Version]
  45. Munyenyembe, A.; Gausi, K.; Nyirenda, T.S.; Hiestand, J.; Mallewa, J.; Mandala, W. HIV infection has a profound effect on hematological factors but not on electrolyte profile of Malawian adults presenting with uncomplicated malaria and severe malaria. J. Blood Med. 2018, 9, 153–162. [Google Scholar] [CrossRef] [Green Version]
  46. Antinori, A.; LaRussa, D.; Cingolani, A.; Lorenzini, P.; Bossolasco, S.; Finazzi, M.G.; Bongiovanni, M.; Guaraldi, G.; Grisetti, S.; Vigo, B.; et al. Prevalence, Associated Factors, and Prognostic Determinants of AIDS-Related Toxoplasmic Encephalitis in the Era of Advanced Highly Active Antiretroviral Therapy. Clin. Infect. Dis. 2004, 39, 1681–1691. [Google Scholar] [CrossRef] [PubMed]
  47. Libório, A.B.; Jr, G.B.S.; Silva, C.G.; Filho, F.J.L.; Neto, A.S.; Okoba, W.; De Bruin, V.M.; Araújo, S.M.H.A.; Daher, E.D.F. Hyponatremia, acute kidney injury, and mortality in HIV-related toxoplasmic encephalitis. Braz. J. Infect. Dis. 2012, 16, 558–563. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Wen, Y.; Zhou, Y.; Wang, W.; Wang, Y.; Lu, X.; Sun, C.M.; Cui, W.; Liu, J.; Geng, W.Q.; Shang, H.; et al. Baseline Factors Associated with Mortality within Six Months after Admission among Hospitalized HIV-1 Patients in Shenyang, China. Intern. Med. 2014, 53, 2455–2461. [Google Scholar] [CrossRef] [Green Version]
  49. Krüger, S.; Ewig, S.; Giersdorf, S.; Hartmann, O.; Frechen, D.; Rohde, G.; Suttorp, N.; Welte, T. Dysnatremia, vasopressin, atrial natriuretic peptide and mortality in patients with community-acquired pneumonia. Respir. Med. 2014, 108, 1696–1705. [Google Scholar] [CrossRef] [Green Version]
  50. Schuetz, P.; Haubitz, S.; Christ-Crain, M.; Albrich, W.C.; Zimmerli, W.; Mueller, B. Hyponatremia and anti-diuretic hormone in Legionnaires’ disease. BMC Infect. Dis. 2013, 13, 585. [Google Scholar] [CrossRef] [Green Version]
  51. Saraya, T.; Nunokawa, H.; Ohkuma, K.; Watanabe, T.; Sada, M.; Inoue, M.; Honda, K.; Oda, M.; Ogawa, Y.; Tamura, M.; et al. A Novel Diagnostic Scoring System to Differentiate between Legionella pneumophila Pneumonia and Streptococcus pneumoniae Pneumonia. Intern. Med. 2018, 57, 2479–2487. [Google Scholar] [CrossRef] [Green Version]
  52. Ito, A.; Ishida, T.; Washio, Y.; Yamazaki, A.; Tachibana, H. Legionella pneumonia due to non-Legionella pneumophila serogroup 1: Usefulness of the six-point scoring system. BMC Pulm. Med. 2017, 17, 1–9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Arancibia, F.; Cortes, C.P.; Valdés, M.; Cerda, J.; Hernández, A.; Soto, L.; Torres, A. Importance of Legionella pneumophila in the Etiology of Severe Community-Acquired Pneumonia in Santiago, Chile. Chest 2013, 145, 290–296. [Google Scholar]
  54. Bellew, S.; Grijalva, C.G.; Williams, D.J.; Anderson, E.J.; Wunderink, R.G.; Zhu, Y.; Waterer, G.W.; Bramley, A.M.; Jain, S.; Edwards, K.M.; et al. Pneumococcal and Legionella Urinary Antigen Tests in Community-acquired Pneumonia: Prospective Evaluation of Indications for Testing. Clin. Infect. Dis. 2019, 68, 2026–2033. [Google Scholar] [CrossRef] [PubMed]
  55. Haubitz, S.; Hitz, F.; Graedel, L.; Batschwaroff, M.; Wiemken, T.L.; Peyrani, P.; Ramirez, J.; Fux, C.A.; Mueller, B.; Schuetz, P. Ruling out Legionella in community-acquired pneumonia. Am. J. Med. 2014, 127, 1010.e11–1010.e19. [Google Scholar] [CrossRef] [PubMed]
  56. Miyashita, N.; Higa, F.; Aoki, Y.; Kikuchi, T.; Seki, M.; Tateda, K.; Maki, N.; Uchino, K.; Ogasawara, K.; Kiyota, H.; et al. Clinical presentation of Legionella pneumonia: Evaluation of clinical scoring systems and therapeutic efficacy. J. Infect. Chemother. 2017, 23, 727–732. [Google Scholar] [CrossRef] [Green Version]
  57. Akyil, F.T.; Akyil, M.; Ağca, M. Çoban; Güngör, A.; Ozantürk, E.; Söğüt, G.; Bekir, S.A.; Topbaş, A.; Türker, H.; Sevim, T. Hyponatremia prolongs hospital stay and hypernatremia better predicts mortality than hyponatremia in hospitalized patients with community-acquired pneumonia. Tuberkuloz Ve Toraks 2019, 67, 239–247. [Google Scholar] [CrossRef]
  58. Jain, D.; Nand, N.; Giri, K.; Bhutani, J. Scrub typhus infection, not a benign disease: An experience from a tertiary care center in Northern India. Med. Pharm. Rep. 2019, 92, 36–42. [Google Scholar] [CrossRef]
  59. Goel, G.A.; Deshpande, A.; Lopez, R.; Hall, G.S.; Van Duin, D.; Carey, W.D. Increased Rate of Spontaneous Bacterial Peritonitis Among Cirrhotic Patients Receiving Pharmacologic Acid Suppression. Clin. Gastroenterol. Hepatol. 2012, 10, 422–427. [Google Scholar] [CrossRef]
  60. Schwabl, P.; Bucsics, T.; Soucek, K.; Mandorfer, M.; Bota, S.; Blacky, A.; Hirschl, A.M.; Ferlitsch, A.; Trauner, M.; Peck-Radosavljevic, M.; et al. Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites. Liver Int. 2015, 35, 2121–2128. [Google Scholar] [CrossRef]
  61. Tseng, M.-H.; Cheng, C.-J.; Sung, C.-C.; Chou, Y.-C.; Chu, P.; Chen, J.-S.; Lin, S.-H. Hyponatremia is a surrogate marker of poor outcome in peritoneal dialysis-related peritonitis. BMC Nephrol. 2014, 15, 1–7. [Google Scholar] [CrossRef] [Green Version]
  62. Ra, G.; Tsien, C.; Renner, E.L.; Wong, F.S.H. The negative prognostic impact of a first ever episode of spontaneous bacterial peritonitis in cirrhosis and ascites. J. Clin. Gastroenterol. 2015, 49, 858–865. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Wang, H.-H.; Huang, C.-H.; Kuo, M.-C.; Lin, S.-Y.; Hsu, C.-H.; Lee, C.-Y.; Chiu, Y.-W.; Chen, Y.-H.; Lu, P.-L.; Lu, P.-L. Microbiology of peritoneal dialysis-related infection and factors of refractory peritoneal dialysis related peritonitis: A ten-year single-center study in Taiwan. J. Microbiol. Immunol. Infect. 2019, 52, 752–759. [Google Scholar] [CrossRef]
  64. Underwood, J.; Cresswell, F.; Salam, A.P.; Keeley, A.J.; Cleland, C.R.; John, L.; Davidson, R.N. Complications of miliary tuberculosis: Low mortality and predictive biomarkers from a UK cohort. BMC Infect. Dis. 2017, 17, 1–7. [Google Scholar] [CrossRef] [Green Version]
  65. Misra, U.K.; Kalita, J.; Bhoi, S.K.; Singh, R.K. A study of hyponatremia in tuberculous meningitis. J. Neurol. Sci. 2016, 367, 152–157. [Google Scholar] [CrossRef] [PubMed]
  66. Afzal, Z.; Kallumadanda, S.; Wang, F.; Hemmige, V.; Musher, D. Acute febrile illness and complications due to murine typhus, Texas, USA. Emerg. Infect. Dis. 2017, 23, 1268–1273. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Tsioutis, C.; Chaliotis, G.; Kokkini, S.; Doukakis, S.; Tselentis, Y.; Psaroulaki, A.; Gikas, A. Murine typhus in elderly patients: A prospective study of 49 patients. Scand. J. Infect. Dis. 2014, 46, 779–782. [Google Scholar] [CrossRef] [PubMed]
  68. Nagappa, M.; Rahul, W.; Sinha, S.; Bindu, P.; Mathuranath, P.; Rao, S.; Periyavan, S.; Rao, G.U.; Taly, A.B. Guillain Barre Syndrome in the elderly: Experience from a tertiary-care hospital in India. J. Clin. Neurosci. 2017, 46, 45–49. [Google Scholar] [CrossRef]
  69. Lien, C.-Y.; Huang, C.-R.; Tsai, W.-C.; Hsu, C.-W.; Tsai, N.-W.; Chang, C.-C.; Lu, C.-H.; Chien, C.-C.; Chang, W.-N. Epidemiologic trend of adult bacterial meningitis in southern Taiwan (2006–2015). J. Clin. Neurosci. 2017, 42, 59–65. [Google Scholar] [CrossRef]
  70. Pereira, G.; Guevara, M.; Fagundes, C.; Solà, E.; Rodríguez, E.; Fernandez, J.; Pavesi, M.; Arroyo, V.; Ginès, P. Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study. J. Hepatol. 2012, 56, 1040–1046. [Google Scholar] [CrossRef]
  71. Song, Y.H.; Shin, T.G.; Kang, M.J.; Sim, M.S.; Jo, I.J.; Song, K.J.; Jeong, Y.K. Predicting Factors Associated With Clinical Deterioration of Sepsis Patients With Intermediate Levels of Serum Lactate. Shock. 2012, 38, 249–254. [Google Scholar] [CrossRef]
  72. Espejo, E.; Andrés, M.; Garcia, M.-C.; Fajardo, A.; Mauri, M.; Pérez, J.; Bella, F. Mediterranean spotted fever in the elderly: A prospective cohort study. Eur. J. Clin. Microbiol. Infect. Dis. 2019, 38, 1333–1337. [Google Scholar] [CrossRef] [PubMed]
  73. Parida, M.; Thatoi, P.K.; Choudhury, A.; Bhuin, S.; Behera, S.; Mohanty, R. Hyponatremia as a Mortality Predictor of Severe Malaria: A Hospital Based Cross-sectional Study. J. Clin. Diagn. Res. 2019, 13, 05–08. [Google Scholar] [CrossRef]
  74. Van Wolfswinkel, M.E.; Hesselink, D.A.; Hoorn, E.J.; De Rijke, Y.B.; Koelewijn, R.; Van Hellemond, J.J.; Van Genderen, P. Copeptin does not accurately predict disease severity in imported malaria. Malar. J. 2012, 11, 6. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. World Health Organization. WHO Severe malaria 2014. Trop. Med. Int. Health 2014, 19 (Suppl. 7–131). Available online: http://www.who.int/malaria/publications/atoz/who-severe-malaria-tmih-supplement-2014.pdf (accessed on 21 April 2020).
  76. Prabhash, K.; Noronha, V.; Goyal, G.; Joshi, A.; Gupta, S.; Ghosh, J.; Bajpai, J.; V, N.; G, G.; A, J.; et al. Presentation, complications, and impact of concurrent malaria infection on anticancer therapy. Indian J. Cancer 2013, 50, 254. [Google Scholar] [CrossRef]
  77. Basu, A.; Ryder, R.E. The syndrome of inappropriate antidiuresis is associated with excess long-term mortality: A retrospective cohort analyses. J. Clin. Pathol. 2014, 67, 802–806. [Google Scholar] [CrossRef]
  78. Shepshelovich, D.; Leibovitch, C.; Klein, A.; Zoldan, S.; Milo, G.; Shochat, T.; Rozen-Zvi, B.; Gafter-Gvili, A.; Lahav, M. The syndrome of inappropriate antidiuretic hormone secretion: Distribution and characterization according to etiologies. Eur. J. Intern. Med. 2015, 26, 819–824. [Google Scholar] [CrossRef]
  79. Shepshelovich, D.; Leibovitch, C.; Klein, A.; Zoldan, S.; Shochat, T.; Green, H.; Rozen-Zvi, B.; Lahav, M.; Gafter-Gvili, A. Yield of workup for patients with idiopathic presentation of the syndrome of inappropriate antidiuretic hormone secretion. Eur. J. Intern. Med. 2016, 32, 60–64. [Google Scholar] [CrossRef]
  80. VanderGheynst, F.; Sakr, Y.; Felleiter, P.; Hering, R.; Groeneveld, J.; Vanhems, P.; Taccone, F.S.; Vincent, J.-L. Incidence and prognosis of dysnatraemia in critically ill patients: Analysis of a large prevalence study. Eur. J. Clin. Investig. 2013, 43, 933–948. [Google Scholar] [CrossRef] [Green Version]
  81. Tsapepas, D.; Chiles, M.; Babayev, R.; Rao, M.K.; Jaitly, M.; Salerno, D.; Mohan, S. Incidence of Hyponatremia with High-Dose Trimethoprim-Sulfamethoxazole Exposure. Am. J. Med. 2016, 129, 1322–1328. [Google Scholar] [CrossRef]
  82. Coppens, R.; Yang, J.; Ghosh, S.; Gill, J.; Chambers, C.; Easaw, J.C. Evaluation of laboratory disturbance risk when adding low-dose cotrimoxazole for PJP prophylaxis to regimens of high-grade glioma patients taking RAAS inhibitors. J. Oncol. Pharm. Pr. 2018, 25, 1366–1373. [Google Scholar] [CrossRef] [PubMed]
Ijerph 17 05320 g001 550
Figure 1. Types of hyponatremia.
Figure 1. Types of hyponatremia.
Ijerph 17 05320 g001
Ijerph 17 05320 g002 550
Figure 2. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2009 flow diagram.
Figure 2. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2009 flow diagram.
Ijerph 17 05320 g002
Table
Table 1. Summary of the most common infectious diseases occurring with hyponatremia.
Table 1. Summary of the most common infectious diseases occurring with hyponatremia.
BacterialViralFungalProtozoal
CAP—mainly caused by Legionella pneumophila
SBP
Tuberculosis
Murine typhus
Sepsis
Meningitidis
Skin and soft tissue infection		HIV/AIDS
HHV-6
Hantavirus
SFTSV
Ebola virus
CNS infections		CryptococcosisMalaria
Abbreviations: CAP—community acquired pneumonia; SBP—spontaneous bacterial peritonitis; HIV—human immunodeficiency virus; AIDS—acquired immune deficiency syndrome; HHV-6—human herpesvirus 6; SFTSV—severe fever with thrombocytopenia syndrome virus; CNS—central nervous system.

Share and Cite

MDPI and ACS Style

Królicka, A.L.; Kruczkowska, A.; Krajewska, M.; Kusztal, M.A. Hyponatremia in Infectious Diseases—A Literature Review. Int. J. Environ. Res. Public Health 2020, 17, 5320. https://doi.org/10.3390/ijerph17155320

AMA Style

Królicka AL, Kruczkowska A, Krajewska M, Kusztal MA. Hyponatremia in Infectious Diseases—A Literature Review. International Journal of Environmental Research and Public Health. 2020; 17(15):5320. https://doi.org/10.3390/ijerph17155320

Chicago/Turabian Style

Królicka, Anna L., Adrianna Kruczkowska, Magdalena Krajewska, and Mariusz A. Kusztal. 2020. "Hyponatremia in Infectious Diseases—A Literature Review" International Journal of Environmental Research and Public Health 17, no. 15: 5320. https://doi.org/10.3390/ijerph17155320

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop